Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist
Clinical trial NCT06851858 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06851858
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-12
- Primary completion
- 2026-05-27
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.